Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.

MLA

Bradshaw, Donald V., Jr, et al. “Genetic Inactivation of SARM1 Axon Degeneration Pathway Improves Outcome Trajectory after Experimental Traumatic Brain Injury Based on Pathological, Radiological, and Functional Measures.” Acta Neuropathologica Communications, vol. 9, no. 1, May 2021, p. 89. EBSCOhost, https://doi.org/10.1186/s40478-021-01193-8.

APA

Bradshaw, D. V., Jr, Knutsen, A. K., Korotcov, A., Sullivan, G. M., Radomski, K. L., Dardzinski, B. J., Zi, X., McDaniel, D. P., & Armstrong, R. C. (2021). Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures. Acta Neuropathologica Communications, 9(1), 89. https://doi.org/10.1186/s40478-021-01193-8

Chicago

Bradshaw, Donald V, Jr, Andrew K Knutsen, Alexandru Korotcov, Genevieve M Sullivan, Kryslaine L Radomski, Bernard J Dardzinski, Xiaomei Zi, Dennis P McDaniel, and Regina C Armstrong. 2021. “Genetic Inactivation of SARM1 Axon Degeneration Pathway Improves Outcome Trajectory after Experimental Traumatic Brain Injury Based on Pathological, Radiological, and Functional Measures.” Acta Neuropathologica Communications 9 (1): 89. doi:10.1186/s40478-021-01193-8.